L. Matthew Posard
Affiliations
- Director at Nautilus Biotechnology Inc. (NAUT), 2023-06-16
- Director at Talis Biomedical Corp (TLIS), 2023-06-12
- Director at Dermtech Inc. (DMTK), 2023-06-05
- at Halozyme Therapeutics Inc. (HALO), 2023-05-09
- Chief Commercial Officer at Trovagene Inc. (TROV), 2016-01-06
- Sr Vp & General Manager at Illumina Inc (ILMN), 2013-05-30
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
NAUT | $4.45 | 10,000 | Director | 50,000 | 2021-12-01 | Filing | |
NAUT | $4.46 | 10,000 | Director | 40,000 | 2021-12-01 | Filing | |
NAUT | $4.50 | 10,000 | Director | 30,000 | 2021-12-01 | Filing | |
NAUT | $4.57 | 20,000 | Director | 20,000 | 2021-11-30 | Filing | |
TLIS | $16.00 | 62,500 | Director | 62,500 | 2021-02-17 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
HALO | $56.12 | 10,000 | 105,189 | 2022-12-06 | Filing | ||
HALO | $55.74 | 10,000 | 115,189 | 2022-12-05 | Filing | ||
HALO | $58.80 | 10,000 | 125,189 | 2022-12-02 | Filing | ||
ILMN | $70.80 | 2,836 | Officer | 30,858 | 2013-05-30 | Filing | |
ILMN | $57.95 | 11,550 | Officer | 30,858 | 2013-04-11 | Filing |